A Phase 1b Trial of a Combination of mFOLFIRI With MEK162 in Patients With Advanced KRAS Positive Metastatic Colorectal Cancers
Phase of Trial: Phase I
Latest Information Update: 21 Feb 2017
At a glance
- Drugs Binimetinib (Primary) ; Fluorouracil; Folinic acid; Irinotecan
- Indications Colorectal cancer
- Focus Adverse reactions
- 15 Feb 2017 Status changed from suspended to recruiting.
- 29 Nov 2016 Status changed from recruiting to suspended.
- 25 May 2016 Status changed from not yet recruiting to recruiting.